DE69810513D1 - Mimetika von beta-faltblatt und verfahren zur verwendung davon - Google Patents

Mimetika von beta-faltblatt und verfahren zur verwendung davon

Info

Publication number
DE69810513D1
DE69810513D1 DE69810513T DE69810513T DE69810513D1 DE 69810513 D1 DE69810513 D1 DE 69810513D1 DE 69810513 T DE69810513 T DE 69810513T DE 69810513 T DE69810513 T DE 69810513T DE 69810513 D1 DE69810513 D1 DE 69810513D1
Authority
DE
Germany
Prior art keywords
beta
mimetic
protein
folder
sheet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69810513T
Other languages
English (en)
Other versions
DE69810513T2 (de
Inventor
N Qaber
K Mcmillian
S Kahn
John E Tulinsky
Jessymol Mathew
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molecumetics Ltd
Original Assignee
Molecumetics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecumetics Ltd filed Critical Molecumetics Ltd
Publication of DE69810513D1 publication Critical patent/DE69810513D1/de
Application granted granted Critical
Publication of DE69810513T2 publication Critical patent/DE69810513T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE69810513T 1998-02-12 1998-02-12 Mimetika von beta-faltblatt und verfahren zur verwendung davon Expired - Lifetime DE69810513T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/002891 WO1999041276A1 (en) 1998-02-12 1998-02-12 β-SHEET MIMETICS AND METHODS RELATING TO THE USE THEREOF

Publications (2)

Publication Number Publication Date
DE69810513D1 true DE69810513D1 (de) 2003-02-06
DE69810513T2 DE69810513T2 (de) 2004-03-18

Family

ID=22266392

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69810513T Expired - Lifetime DE69810513T2 (de) 1998-02-12 1998-02-12 Mimetika von beta-faltblatt und verfahren zur verwendung davon

Country Status (9)

Country Link
EP (1) EP1053246B1 (de)
JP (1) JP2002503674A (de)
KR (1) KR20010040939A (de)
AT (1) ATE230414T1 (de)
AU (1) AU748887B2 (de)
CA (1) CA2319766A1 (de)
DE (1) DE69810513T2 (de)
ES (1) ES2192764T3 (de)
WO (1) WO1999041276A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1261611A2 (de) * 2000-02-29 2002-12-04 Bristol-Myers Squibb Pharma Company Inhibitoren der hepatitis-c-virus-ns3-protease
US6534651B2 (en) * 2000-04-06 2003-03-18 Inotek Pharmaceuticals Corp. 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
US20060276497A1 (en) 2000-05-09 2006-12-07 Cephalon, Inc. Novel multicyclic compounds and the use thereof
US7122679B2 (en) 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
WO2003068237A1 (en) * 2002-02-14 2003-08-21 Myriad Genetics, Inc. Beta-sheet mimetics and composition and methods relating thereto
US20110212078A1 (en) * 2008-06-25 2011-09-01 Reddy Panduranga Adulla P Synthesis and use of heterocyclic antibacterial agents
PE20171335A1 (es) 2014-10-06 2017-09-13 Cortexyme Inc Inhibidores de gingipaina de lisina
JP6877424B2 (ja) 2015-11-09 2021-05-26 コーテクシーミー， インコーポレイテッド アルギニンジンジパインの阻害剤
ES2903283T3 (es) 2016-08-31 2022-03-31 Jiangsu Hengrui Medicine Co Derivado de oxipicolinamida, método de preparación y uso farmacéutico del mismo
BR112019004864A8 (pt) 2016-09-16 2023-03-07 Cortexyme Inc Inibidores cetona de lisina gingipain
CN112004810B (zh) 2018-07-02 2022-04-08 江苏恒瑞医药股份有限公司 一种氧代吡啶酰胺类衍生物的晶型及制备方法
WO2021057818A1 (zh) 2019-09-27 2021-04-01 深圳信立泰药业股份有限公司 FXIa抑制剂及其制备方法和医药用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69317764T2 (de) * 1992-02-14 1998-07-30 Merrell Pharmaceuticals Inc., Cincinnati, Ohio Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
ES2138622T3 (es) * 1992-05-15 2000-01-16 Merrell Pharma Inc Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca.
EP0618223A3 (de) * 1993-03-08 1996-06-12 Sandoz Ltd Peptide, die Freisetzung vom Interleukin 1-Bêta, nützlich als entzündungshemmende Wirkstoffe.
SK83897A3 (en) * 1994-12-22 1998-05-06 Iaf Biochem Int Low molecular weight bicyclic thrombin inhibitors
WO1996030396A1 (en) * 1995-03-24 1996-10-03 Molecumetics Ltd. β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS
JPH10508034A (ja) * 1995-03-24 1998-08-04 モレキュメティックス リミテッド βシート模倣物および生物学的に活性なペプチドまたはタンパク質のインヒビターとしてのその使用
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
IT1277405B1 (it) * 1995-08-01 1997-11-10 Menarini Farma Ind Derivati di lattami biciclici come inibitori della trombina
WO1998005333A1 (en) * 1996-08-05 1998-02-12 Molecumetics Ltd. Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors

Also Published As

Publication number Publication date
ES2192764T3 (es) 2003-10-16
CA2319766A1 (en) 1999-08-19
JP2002503674A (ja) 2002-02-05
ATE230414T1 (de) 2003-01-15
AU6655798A (en) 1999-08-30
KR20010040939A (ko) 2001-05-15
AU748887B2 (en) 2002-06-13
WO1999041276A1 (en) 1999-08-19
DE69810513T2 (de) 2004-03-18
EP1053246A1 (de) 2000-11-22
EP1053246B1 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
DE69735545D1 (de) Verwendung von beta-blatt mimetika als protease und kinase hemmer und alshemmer eines transkriptionsfaktors
EP1408986A4 (de) Proteomimetische verbindungen und verfahren
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
ATE269295T1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
DE69429527D1 (de) Inhibitoren von beta-amyloid-protein-herstellung
DE60023936D1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
ATE497783T1 (de) Gerinnungsfaktor vii-fc chimäre proteine zur behandlung von hämostatischen krankheiten
DE60025812D1 (de) Jak-3 hemmer zur behandlung von allergischen störungen
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
DE69810513D1 (de) Mimetika von beta-faltblatt und verfahren zur verwendung davon
MY140132A (en) Thiazolidin-4-one derivatives for use in the treatment of anemias
DE60007095T2 (de) Calanolide zur hemmung von btk
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
ATE521357T1 (de) Verfahren zur behandlung von hepatitis
CY1107640T1 (el) Μεθοδος για πιστοποιηση παραγοντων για τη θεραπεια διαβητη
TW200700089A (en) Recombinant protein comprising starch binding domain and use thereof
ATE342976T1 (de) Cytokinrezeptor-kette
DE60016405D1 (de) Neurodegenerative-erkrankung verwandtes gen
ATE267194T1 (de) Medikamente geeignet zur behandlung von proliferativen erkrankungen
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.
NZ505980A (en) Beta-sheet mimetics
ATE364180T1 (de) Screeningverfahren mit bnpi und dnpi
DE60120187D1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
DE69521281D1 (de) Verfahren zur Herstellung von menschlichem oder humanem Matrilysin mittels rekombinanter DNA.
SE0202608D0 (sv) New sequences

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted